Feature | April 08, 2011

Egyptian Mummies Show Earliest Cases of Coronary Disease on CT

Proof of heart disease dating back 3,550 years prompts researchers to question whether there is a missing link in understanding this “modern” condition

Calcification in in the aortic bifurcation of an Egyptian mummy.

Annular valve stenosis in the heart of an Egyptian mummy.

Carotid stenosis in an Egyptian mummy.

Coronary stenosis in the heart of an Egyptian mummy.

Peripheral artery disease in an Egyptian mummy.

A U.S.-Egyptian research team has uncovered the earliest documented case of coronary atherosclerosis in a princess who died in her early 40s and lived between 1580 and 1550 B.C. Of the other mummies studied – a sampling of the elite in ancient Egypt – almost half showed evidence of atherosclerosis in one or more of their arteries, calling into question our perception of atherosclerosis as a modern disease, according to research presented this week at the American College of Cardiology (ACC) Scientific Session in New Orleans.

While atherosclerosis has been observed before in ancient Egyptians, this study found it to be more prevalent than previously thought. The interdisciplinary team performed whole body computerized tomography (CT) scans on 52 ancient Egyptian mummies to determine if atherosclerosis was present. Of the 44 with identifiable arteries or hearts, nearly half (45 percent) had calcifications either in the wall of an artery or along the course of an artery that are diagnostic of or highly suggestive of atherosclerosis. “Commonly, we think of coronary artery or heart disease as a consequence of modern lifestyles, mainly because it has increased in developing countries as they become more westernized,” said Gregory S. Thomas, M.D., MPH, clinical professor and director of nuclear cardiology education, University of California, Irvine and the study’s co-principal investigator.

“These data point to a missing link in our understanding of heart disease, and we may not be so different from our ancient ancestors.” Most of the atherosclerosis was found in the large arteries of the body, including the aorta in the abdomen. However, key smaller arteries were also involved. About 7 percent of the mummies had obstructions in the heart arteries, and 14 percent had blockages in the arteries to the brain, the carotid arteries, which is a leading cause of stroke in the present day. Researchers also found that, similar to now, advancing age was highly predictive of the presence and severity of atherosclerosis.

Thomas explains that the calcific atherosclerosis seen with CT scanning looks just like the atherosclerosis of today and appears in the same locations. While researchers could not determine the exact cause of death in these mummies, symptoms consistent with cardiac chest pain had been described in ancient Egyptian scrolls. In order to understand the lifestyles of ancient Egypt’s elite, the team of researchers worked with Egyptologists to review risk factors that might affect the health of the heart and arteries.

“We suspect, but do not know, that meat, which was certainly leaner at that time, was a smaller part of their diet than ours today,” Thomas said. “We know that Egyptians had an overall better diet, did not smoke cigarettes and were more active – yet they still have the same disease we have. This discovery points to the fact that we don’t understand atherosclerosis and heart disease as well as we think we do.”

Although the findings require further study, Thomas and his co-principal investigator, Adel Allam, M.D., of Al Azhar University, Cairo, Egypt believe these data suggest that genetic factors resulting in atherosclerosis are more important than previously thought. They caution, however, that the genetic factors that may predispose us to the disease are even more compelling reasons to carefully manage risk factors that we have some control over, if not to prevent atherosclerosis, to minimize its impact.

“Recent studies have shown that by not smoking, having a lower blood pressure and a lower cholesterol level, calcification of our arteries is delayed,” said Allam. “On the other hand, from what we can tell from this study, humans are predisposed to atherosclerosis, so it behooves us to take the proper measures necessary to delay it as long as we can.”

Mummies were preserved by going through a 70-day sterilization and dehydration process using natron, a mixture of sodium carbonate, sodium bicarbonate, sodium sulfate and sodium chloride, which allows the bodies to be recognizable and studied 3,500 or more years later. The study was funded by the National Bank of Egypt, Siemens and the St. Luke’s Hospital Foundation. Cardiology co-investigators include: doctors. Randall Thompson of the St. Luke’s Mid-America Heart Institute, Kansas City, Mo.; Sam Wann of the Wisconsin Heart Hospital, Milwaukee, Wis.; and Michael I. Miyamoto of the Mission Internal Medical Group, Mission Viejo, Calif.

This study is published in print and online in the JACC: Cardiovascular Imaging April 2011 edition.

Related Content

bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the a Volcano IVUS system and the left image in from St. Jude Medical's OCT system.


Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS
News | Congenital Heart| October 19, 2016
St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional Sizes) pediatric...
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab| October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
3-D bioprinting, 3-D printing, printed organs, 3D bioprinting

3-D printed vessel made from living cells implanted in an animal to test feasibility of using such structures clinically. Blood vessels are a stepping stone to the creation of more complex 3-D printed organs made from biomaterials. Image from the South Carolina Project for Organ Biofabrication.


Feature | 3-D Printing| October 13, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) changed its rules concerning custom medical devices Oct.
Overlay Init